Results 181 to 190 of about 23,170 (228)

Red blood cell alloantibodies dictating solid organ transplant decisions: Two case reports. [PDF]

Asian J Transfus Sci
Banerjee S, Arpitha P, Reddy TV, Chakraborty S, Mathur A.   +4 more
europepmc   +1 more source

Non-HLA Genetics and Application to Living Donor Candidates. [PDF]

Curr Transplant Rep
Caliskan Y, Afsar B, Afsar RE, Varma C, Aygormez O, Lentine KL.   +5 more
europepmc   +1 more source

Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members.

Blood, 2009
van Halteren AG, Jankowska-Gan E, Joosten A, Blokland E, Pool J, Brand A, Burlingham WJ, Goulmy E.   +7 more
europepmc   +1 more source

Advances in African swine fever vaccine development: challenges and prospects. [PDF]

J Vet Sci
Utomo DIS, Dharmayanti NI, Putra MY.
europepmc   +1 more source

Case Report: donor cell-derived leukemia after allogeneic stem cell transplantation for metastatic renal cell carcinoma. [PDF]

Front Immunol
Monaco F, Tran DT, Sandmaier BM, Tykodi SS.   +3 more
europepmc   +1 more source

Clinicopathological Characteristics of Acute Antibody-Mediated Rejection in Pediatric Liver Transplantation-A Single-Center Study. [PDF]

J Clin Med
Szymanska S, Piątosa B, Ciopiński M, Kijewski A, Kaliciński P, Markiewicz-Kijewska M.   +5 more
europepmc   +1 more source

Knowledge-based immune-therapeutic advances for transplantation and cancer. [PDF]

Immunother Adv
Simpson E.
europepmc   +1 more source

Nature of the minor Histocompatibility antigens.

, 1997
openaire   +1 more source

Human minor histocompatibility antigens

Current Opinion in Immunology, 1996
Disparities in minor histocompatibility antigens between HLA-matched organ and bone marrow donors and recipients create a potential risk for graft failure and graft-versus-host disease. These conditions necessitate lifelong pharmacological immunosuppression of organ and bone marrow transplant recipients.
E Goulmy, Els Goulmy
exaly   +6 more sources